Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerThomas Reinert, Claus L. Andersen, Kåre Andersson Gotschalck et al.|JAMA Oncology|2019Cited by 992
Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal CancerJesper Nors, Claus L. Andersen, Lene Hjerrild Iversen et al.|JAMA Oncology|2023Cited by 149
Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Annals of Oncology|2023Cited by 71
IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2. Study protocolJesper Nors, Claus L. Andersen, Tenna Vesterman Henriksen et al.|Acta Oncologica|2020Cited by 46
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Claus L. Andersen, Jesper Nors et al.|European Journal of Cancer|2024Cited by 19